# Dennis Mehiel

> Dennis Mehiel is a Series A investor backing Life Science, Biotechnology and Venture Capital. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Sep 2022
- Lead investor: 0%
- Last updated: Aug 2026

Dennis Mehiel is an American entrepreneur and investor, best known as the founder of Box USA. He has held leadership roles across business and public policy organizations and serves on the Board of Directors of the American Security Project.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Venture Capital | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Proto Axiom | Australia produces world leading intellectual property in drug development and medical equipment, yet captures virtually none of the downstream commercialisation and job multipliers. This is in part due to underdeveloped domestic preclinical expertise. Proto Axiom on shores this capacity, keeping Australian IP in Australia. | $9.7M | Series A | Sep 27, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 2 deals together
- [Churchill Asset Management](https://shizune.co/investors/profile/churchill-asset-management) — VC Fund, 1 deal together
- [HOF Capital](https://shizune.co/investors/profile/hof-capital) — VC Fund, 1 deal together
- [Parkview International](https://shizune.co/investors/profile/parkview-international-inc) — VC Fund, 1 deal together
- [Paul Little’s family office](https://shizune.co/investors/profile/paul-little-s-family-office) — VC Fund, 1 deal together
- [Riverlane Capital](https://shizune.co/investors/profile/riverlane-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Life Science Investors in Oceania](https://shizune.co/investors/life-science-investors-oceania)
- [Biotechnology Angel Investors in Australia](https://shizune.co/investors/biotechnology-angel-investors-australia)
- [Biotech Angel Investors in Australia](https://shizune.co/investors/biotech-angel-investors-australia)

## FAQ

### What does Dennis Mehiel invest in?

Dennis Mehiel invests primarily in Life Science, Biotechnology and Venture Capital startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dennis Mehiel last invest?

The most recent investment recorded for Dennis Mehiel closed in Sep 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co